A major shift in federal marijuana policy is forcing employers to rethink workplace drug policies and disability accommodations. The recent reclassification of medical marijuana from a Schedule I controlled substance to a Schedule III substance has changed how employers must evaluate employee marijuana use under the Americans with Disabilities Act (ADA). For many organizations, this change introduces legal uncertainty and a need for immediate policy review.
Under the ADA, individuals currently engaged in the illegal use of drugs have historically not been protected. Because marijuana was previously categorized as a Schedule I drug, employers could deny accommodation requests involving medical marijuana without extensive legal analysis. Marijuana’s classification as having no accepted medical use allowed employers to rely on federal illegality when making employment decisions.
The reclassification changes that framework significantly. Medical marijuana and FDA approved marijuana products are now viewed more similarly to prescription medications. Employers can no longer automatically reject accommodation requests based solely on marijuana’s federal status. Instead, employers are expected to follow the ADA’s standard accommodation process by engaging in an interactive discussion with employees and determining whether a reasonable accommodation can be provided for a qualifying disability.
Despite this shift, employers still maintain the right to enforce drug free workplace policies and prohibit employees from working while impaired. Safety concerns and job performance standards remain valid reasons for disciplinary action. Employers are not required to tolerate unsafe workplace behavior or impaired performance simply because marijuana use is medically authorized.
The focus now moves toward individualized assessments. Employers must consider whether an employee’s marijuana use is lawful and medically authorized, whether the employee’s condition qualifies for ADA protection, the essential duties of the employee’s position, and whether accommodating marijuana use would create a direct threat or undue hardship for the organization.
Safety sensitive positions remain especially complicated. Employees working in transportation, construction, healthcare, or federally regulated industries may still face strict restrictions on marijuana use. Federal contractors and employers regulated by the Department of Transportation should continue monitoring developments closely because federal drug testing policies have not yet changed.
As courts begin addressing disputes related to marijuana accommodations and workplace discipline, employers should expect additional legal guidance in the coming years. In the meantime, organizations should review drug testing procedures, update accommodation policies, and provide supervisor training to ensure compliance with evolving federal and state laws. The June 29, 2026, hearing on broader marijuana rescheduling may further shape the future of workplace drug policies and employer responsibilities.
ASE Connect
Drug Screening: ASE helps employers maintain safe, productive, and drug-free workplaces with reliable drug screening programs. We support pre-employment, random, post-incident, and ongoing testing needs through flexible, compliant solutions tailored to your organization’s policies and workforce requirements.
Policy Updates: ASE helps employers keep their handbooks up to date with evolving employment laws, including requirements under the Americans with Disabilities Act (ADA). Our HR experts can review and update ADA-related policies to ensure they are clear, compliant, and aligned with current workplace practices, helping employers effectively support employees while reducing compliance risks.
Supervisor Training: ASE offers training in the area of ADA compliance. View our upcoming courses: